Search results for abx831341

Istiratumab, Abbexa, abx831341

Istiratumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB3/IGF1R/CD221, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Istiratumab is under investigation in clinical trial NCT02399137 (A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer).